Adult Intraventricular Hemorrhage Market Report 2026

Adult Intraventricular Hemorrhage Market Overview

• Adult Intraventricular Hemorrhage market size has reached to $2.22 billion in 2025 • Expected to grow to $2.9 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% • Growth Driver: Growth Of Adult Intraventricular Hemorrhage Market Driven By Increasing Stroke Incidence • Market Trend: Innovative Neuroaccess Devices Enhancing Neurovascular Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Adult Intraventricular Hemorrhage Market?

Adult intraventricular hemorrhage (IVH) is a type of bleeding that occurs within the brain's ventricular system, where cerebrospinal fluid is produced and circulates. It often results from trauma, stroke, or other conditions that cause blood vessels in the brain to rupture. IVH can lead to increased intracranial pressure, hydrocephalus, and neurological damage, requiring prompt medical intervention. The main product types of adult intraventricular hemorrhage are surgical devices, drugs, and monitoring devices. Surgical devices are specialized tools or instruments used during surgeries to perform specific actions or achieve certain outcomes in medical procedures. It is distributed through various channels, such as direct sales, distributors, online platforms, and others, and it is used in various applications, including intraventricular hemorrhage, intracerebral hemorrhage, subarachnoid hemorrhage, and others. It is used by various end-users, such as hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers, and others.

What Is The Adult Intraventricular Hemorrhage Market Growth Forecast?

The adult intraventricular hemorrhage market size is expected to see strong growth in the next few years. It will grow to $2.9 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to development of minimally invasive surgical devices, increasing use of smart monitoring technologies, rising adoption of novel hemostatic and neuroprotective drugs, expansion of ivh-focused clinical research, growing demand for homecare and ambulatory intervention solutions. Major trends in the forecast period include rising adoption of external ventricular drainage (evd) systems, increasing use of minimally invasive neurosurgical tools, growing demand for hemostatic and antihypertensive drugs, expansion of advanced intracranial monitoring devices, focus on rapid diagnosis and early intervention in ivh.

Global Adult Intraventricular Hemorrhage Market Segmentation

1) By Product Type: Surgical Devices, Drugs, Monitoring Devices 2) By Distribution Channel: Direct Sales, Distributors, Online Platforms, Other Distribution Channels 3) By Application: Primary Intraventricular Hemorrhage, Secondary Intraventricular Hemorrhage, Post-Traumatic Intraventricular Hemorrhage, IVH with Hydrocephalus, Other Applications 4) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users Subsegments: 1) By Surgical Devices: Craniotomy Instruments, External Ventricular Drainage (EVD) Systems, Surgical Clips And Staples, Endoscopic Tools 2) By Drugs: Hemostatic Agents, Antihypertensive Drugs, Sedatives And Analgesics 3) By Monitoring Devices: Intracranial Pressure (ICP) Monitors, Brain Oxygenation Monitors, Cerebral Blood Flow (CBF) Monitors, Neuroimaging Devices

What Is The Driver Of The Adult Intraventricular Hemorrhage Market?

The increasing incidence of strokes is expected to propel the growth of the adult intraventricular hemorrhage market going forward. A stroke is a medical emergency that occurs when blood flow to the brain is interrupted or reduced, leading to brain cell damage. The increasing incidence of strokes is primarily due to factors such as an aging population, rising rates of hypertension, diabetes, and obesity, and lifestyle-related risk factors such as smoking and physical inactivity. Strokes can cause adult intraventricular hemorrhage (IVH) by leading to bleeding within the brain's ventricular system, often due to ruptured blood vessels. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based independent statutory government agency, in 2023, Australia recorded approximately 41,100 stroke incidents, averaging about 113 cases each day. Therefore, the increasing incidence of strokes is driving the growth of the adult intraventricular hemorrhage industry.

Key Players In The Global Adult Intraventricular Hemorrhage Market

Major companies operating in the adult intraventricular hemorrhage market are Johnson and Johnson, Abbott Laboratories, Medtronic Plc, Siemens Healthineers, Medline Industries, Philips Healthcare Inc., Stryker Corporation, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Alcon Inc., Zimmer Biomet Holdings Inc., Olympus Corporation, Smith and Nephew, Kaneka Corporation, Karl Storz SE and Co. KG, Carl Zeiss Meditec AG, Integra Lifesciences Holdings Corp, Elekta AB, Leica Microsystems GmbH, KLS Martin Group, Natus Medical Incorporated, Aesculap Inc., NeuroPace Inc., Sophysa USA Inc, Spiegelberg GmbH and Co. KG, Vivonics Inc.

Global Adult Intraventricular Hemorrhage Market Trends and Insights

Major companies operating in the adult intraventricular hemorrhage market are focused on developing innovative products, such as neuroaccess devices, for neurovascular management of ischemic and hemorrhagic strokes. Neuroaccess devices are medical tools used to gain entry to the brain or spinal cord for diagnostic or therapeutic procedures. For instance, in June 2024, Penumbra Inc., a US-based medical device company, announced the CE Mark approval and European launch of its BMX81 and BMX96 neuroaccess devices for managing ischemic and hemorrhagic stroke. These devices are designed for the neurovascular management of ischemic and hemorrhagic strokes and are Penumbra's most advanced neuroaccess offerings. Unlike traditional access catheters, the BMX81 and BMX96 are made using laser-cut stainless steel hypo tube technology, offering stability and trackability to allow physicians to easily navigate the brain's complex anatomy.

What Are Latest Mergers And Acquisitions In The Adult Intraventricular Hemorrhage Market?

In April 2024, Viz.ai, a US-based digital health company, partnered with Nico Corporation to enhance the treatment of intracerebral hemorrhage. Through this collaboration, Viz.ai aims to integrate Nico’s surgical and monitoring devices with its AI-powered stroke care platform, improving timely diagnosis, intervention, and patient outcomes in hemorrhagic stroke cases. Nico Corporation is a US-based medical technology company that specializes in neurosurgical devices and monitoring solutions used in the management of intracerebral and intraventricular hemorrhages.

Regional Outlook

North America was the largest region in the adult intraventricular hemorrhage market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adult Intraventricular Hemorrhage Market?

The adult intraventricular hemorrhage market consists of revenues earned by entities by providing services such as neurological assessment and monitoring, physical therapy to regain motor skills and strength, and interventional radiology for endovascular procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The adult intraventricular hemorrhage market also includes sales of neuroendoscopic instruments, antiepileptic drugs, and osmotic diuretics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Adult Intraventricular Hemorrhage Market Report 2026?

The adult intraventricular hemorrhage market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adult intraventricular hemorrhage industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.